The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Mydriacyl
tropicamide · TROPICAMIDE 10 mg/mL · Solution/ Drops · Ophthalmic · Alcon Laboratories, Inc.
NDC 00065-0355-03 · 1 BOTTLE in 1 CARTON / 3 mL in 1 BOTTLE · ANDA · View full market →
One drug, every price
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
ⓘ How this was built
Data sources
- CMS NADAC (pharmacy acquisition, weekly)
- CMS Part B ASP quarterly payment limits
- CMS Maximum Fair Prices (IRA negotiated, NDC-level)
- Medicare Part D Spending by Drug (data.cms.gov, name-matched)
- VA FSS / Big4 federal contract prices (va.gov, twice monthly)
- ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
- California SB-17 WAC filings (list price, per package)
Method
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
- Part D plans paid (avg)$1.46per dosage unitgross, before rebates — matched by drug name · 2024
- Medicaid generic ceiling (FUL)$2.31per MLweighted avg manufacturer price $1.3204 · Feb 1, 2018
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.2%chance of a new FDA shortage posting for tropicamide (other) in the next 90 days
OAI inspection at a producing facility (24 months) · price up 12% YoY · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Alcon Research LLCUnited Statesmanufacture
- Carbogen Amcis AgSwitzerlandapi manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA084306
- TE code
- AT
- Approval date
- Jan 1, 1982
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of tropicamide (Solution/ Drops)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bausch & Lomb Incorporated | TROPICAMIDE 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Bausch & Lomb Incorporated | TROPICAMIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sandoz Inc | TROPICAMIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sandoz Inc | TROPICAMIDE 5 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Somerset Therapeutics, LLC | TROPICAMIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sportpharm LLC | TROPICAMIDE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Alcon Laboratories, Inc. | TROPICAMIDE 10 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Mydriacyl — NDC 00065-0355-03," retrieved September 3, 2026, https://drugdashboards.com/drug/00065035503.
Free to cite with attribution — see how the data is put together.